Service Platform

Home page

Service Platform

Related Services and Solutions

We look forward to working with you and providing you with excellent service.

Small Molecule CDMO Services

Jiuzhou Pharma provides customers worldwide with quality one-stop CDMO services throughout the entire industry chain, from preclinical chemical manufacturing and control (CMC) through phase I/II/III clinical trials and new drug applications (NDA) to global marketing.

Efficient, professional, international R&D team for small-molecule APIs

1000 +

scientific research personnel

(This data is as of the half year of 2023)

900 +

New Drug Project

scientific research personnel

Commercialization Project

scientific research personnel

Pilot-scale production for various specifications

cGMP Kilo Lab

Number of reactors: 43

Reactor size: 20–750 L

Stainless steel pressure reactors: 19 L

Pressure reactors: 0.5–2.0 L

Stainless steel basket centrifuge

Ozone generator

cGMP实验室 (台州)

反应釜个数:43个
反应釜规模 :20 - 750L
不锈钢压力反应釜:19L
压力反应釜:0.5 - 2.0L
不锈钢篮式离心机
臭氧发生器

cGMP实验室 (美国)

反应釜规模:72- 750L
不锈钢压力反应釜:19L
压力反应釜:0.5-2.0L
不锈钢篮式离心机
臭氧发生器
公斤级cGMP批次生产

cGMP实验室 (台州)

反应釜个数:43个
反应釜规模 :20 - 750L
不锈钢压力反应釜:19L
压力反应釜:0.5 - 2.0L
不锈钢篮式离心机
臭氧发生器

cGMP实验室 (美国)

反应釜规模:72- 750L
不锈钢压力反应釜:19L
压力反应釜:0.5-2.0L
不锈钢篮式离心机
臭氧发生器
公斤级cGMP批次生产

中试车间 (台州)

生产车间: 8个
反应釜个数:208个
反应釜规模 :30 - 2,000L
反应温度最高:250 ℃
反应温度最低:- 80 ℃

中试车间 (杭州)

生产车间: 8个
反应釜个数:208个
反应釜规模 :30 - 2,000L
反应温度最高:250 ℃
反应温度最低:- 80 ℃

Pilot Plant

Production workshops: 8

Number of reactors: 208

Reactor size: 30–2,000 L

Max. reaction temperature: 250°C

Min. reaction temperature: -80°C

Commercial production of APIs for diverse needs

Our multi-site manufacturing network consists of over 50 production lines in large specialized workshops, multipurpose workshops, and pilot plants, offering kilogram- to tonne-scale manufacturing capabilities that accommodate different demands.

Our production facilities are fitted with state-of-the-art, cGMP-qualified API production equipment that facilitate a range of reactions, including high-pressure dehydrogenation and cryogenic reactions. We also built production facilities for highly potent compounds, featuring two OEB 5 and six OEB 4 production lines.

Our production bases utilize automated technologies, including distributed control systems (DCS), to enable automated temperature control and inert gas sample transfer modules. We also implement safety instrumented systems (SIS) for hazardous processes to achieve safe and stable intelligent manufacturing.